(1)
Health Economic Implications of Irbesartan Plus Conventional Antihypertensive Medications Versus Conventional Blood Pressure Control Alone in Patierns With Type 2 Diabetes, Hypertension, and Renal Disease in Switzerland. Swiss Med Wkly 2006, 136 (2122), 346-346. https://doi.org/10.57187/smw.2006.11337.